Header Logo
Newsletter Podcast
Log In
← Back to all posts

Better Outcomes, Better Marketing, Bigger Impact

Jul 15, 2025
Connect

Highlights

  • Today’s Research Article: PRP Outperforms Steroids in Knee OA Relief and the Results Last.
  • Questions from the Field: It’s Not the Centrifuge, It’s What You Do With It.
  • Let’s Get Down to Business: Stop blending in. Learn how patient stories and consistency can turn followers into patients.
  • Come Join Us: Join us in Vegas this July and August for two powerful regenerative medicine experiences you won’t want to miss.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Clinical and Biochemical Correlation of Intraarticular Platelet-Rich Plasma and Corticosteroid Using Serum Matrix Metalloproteinase 3 (MMP-3) Levels in Osteoarthritis of Knee

Vaneet Arora, Manmohan Sharma, Sandeep Bishnoi, Vakul Mahipal, Angad S. Sandhu, Rajat Khanna, Tarun Aggarwal, Krishnadev S. Yadav, Gautam Jain, Shubham M. Sharma

Read the full article here.

Summary:

This study compared the clinical and biochemical outcomes of intra-articular Platelet-Rich Plasma (PRP) versus corticosteroid (CS) injections in patients with knee osteoarthritis (OA). A total of 87 patients with Kellgren-Lawrence grade II and III knee OA were randomly assigned to receive a single injection of either PRP or methylprednisolone. Outcomes were assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Visual Analogue Scale (VAS), and serum levels of Matrix Metalloproteinase-3 (MMP-3). Patients were followed up over nine months.

The findings revealed that PRP provided significantly greater and longer-lasting improvements in pain, stiffness, and joint function compared to CS, as evidenced by lower WOMAC and VAS scores at the 6- and 9-month marks. However, neither treatment led to a significant change in serum MMP-3 levels, suggesting that while both offer symptomatic relief, neither appears to alter cartilage degeneration biochemically. PRP was also found to be safe and minimally invasive, reinforcing its clinical utility in OA knee management.

Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP’s edge on back pain, smarter marketing, and a live demo invite
Highlights Today’s Research Article: PRP outlasts steroids—stronger, safer, longer relief for back pain. Questions from the Field: From blood draw to injection: PRP takes just 20–25 minutes. Let’s Get Down to Business: Marketing isn’t sales—it’s how patients discover you. Come Join Us: See PRP in action—live demo & Q&A with Dr. Ariana DeMers.   If this newsletter was forwarded to you and you...
Stronger Shoulders, Smarter PRP, Better Marketing
Highlights Today’s Research Article: PRP beats PT in restoring shoulder function—lasting results without surgery. Questions from the Field: Not all PRP systems are equal—know your spin, know your outcomes. Let’s Get Down to Business: Doctors shouldn’t market alone—team up and thrive in today’s digital age. Come Join Us: Turn orthobiologic knowledge into profit at BOB Live—your Monday-r...
Grade IV OA? PRP Delivers – Plus, What to Do When Patients Don’t Respond
Highlights Today’s Research Article: Grade IV knee arthritis patients move better, hurt less, and skip the scalpel. Questions from the Field: When PRP results fall short, smart testing and re-dosing can turn non-responders into success stories. Let’s Get Down to Business: Connect, refer, and watch your practice grow. Come Join Us: BOB Live turns knowledge into profit   Turn what you...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.